Physician profile
Renee Lee
NPI 1336729151
$875.07
in general payments reported to CMS, 2019-2025
10 companies · $459 in 2025
The $459 reported for 2025 was more than what 78% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $416 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Travel and Lodging: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.67 |
| Travel and Lodging | $147.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $237.77 | 2024 | Vasoview Hemopro 2, Acrobat-I Stabilizer |
| Abiomed | $231.55 | 2025 | |
| Arthrex, INC. | $106.45 | 2025 | |
| Atricure, INC. | $73.66 | 2024 | |
| Medtronic, INC. | $57.17 | 2024 | Penditure |
| Solventum Corporation | $50.36 | 2025 | Prevena |
| Edwards Lifesciences Corporation | $49.78 | 2025 | Inspiris Resilia Aortic Valve |
| Guard Medical INC. | $27.27 | 2024 | Npseal Large |
| Inspiremd LTD | $20.62 | 2025 | Cguard Prime Carotid Stent System |
| Baxter Healthcare | $20.44 | 2024 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.